Currax Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Currax Pharmaceuticals has a total of 74 patents globally, out of which 50 have been granted. Of these 74 patents, more than 64% patents are active. United States of America is where Currax Pharmaceuticals has filed the maximum number of patents, followed by Europe and Austria. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Currax Pharmaceuticals.

Currax Pharmaceuticals was founded in the year 2019. The Company operates as a specialty pharmaceutical company. The Company focuses on acquiring and commercializing branded and generic pharmaceutical products.

Do read about some of the most popular patents of Currax Pharmaceuticals which have been covered by us in this article and also you can find Currax Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Currax Pharmaceuticals patent portfolio.

How many patents does the CEO of Currax Pharmaceuticals have?

The CEO George Hampton has 6 patents.

How many patents does Currax Pharmaceuticals have?

Currax Pharmaceuticals has a total of 74 patents globally. These patents belong to 19 unique patent families. Out of 74 patents, 48 patents are active.

How Many Patents did Currax Pharmaceuticals File Every Year?

Currax Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCurrax Pharmaceuticals Applications FiledCurrax Pharmaceuticals Patents Granted
202211
202134
202037
2019511
201867
201744
201665
201532
20143
201372
201272

How many Currax Pharmaceuticals patents are Alive/Dead?

Currax Pharmaceuticals Patent Portfolio

 How Many Patents did Currax Pharmaceuticals File in Different Countries?

Currax Pharmaceuticals Worldwide Patent Filing

Countries in which Currax Pharmaceuticals Filed Patents

CountryPatents
United States Of America54
Europe5
Austria4
Germany4
Spain3
Australia2
Singapore2

Where are Research Centres of Currax Pharmaceuticals Patents Located?

The Research Centre for all the Currax Pharmaceuticals patents is the United States of America.

10 Best Currax Pharmaceuticals Patents

US7915307B2 is the most popular patent in the Currax Pharmaceuticals portfolio. It has received 29 citations so far from companies like Somaxon Pharmaceuticals, Pernix Sleep and Orexigen Therapeutics.

Below is the list of 10 most cited patents of Currax Pharmaceuticals:

Publication NumberCitation Count
US7915307B229
US20110318412A129
US7094429B211
US20140364468A110
US20130245056A18
US8247000B26
US7943597B26
US20130150434A15
US9394318B24
US7273623B24

What are Currax Pharmaceuticals key innovation segments?

What Technologies are Covered by Currax Pharmaceuticals?

The chart below distributes patents filed by Currax Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Currax Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Currax Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Currax Pharmaceuticals?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.